DaVita
DVA
#1738
Rank
NZ$21.43 B
Marketcap
NZ$335.94
Share price
-0.45%
Change (1 day)
53.22%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): NZ$18.80

According to DaVita's latest financial reports the company's current EPS (TTM) is NZ$19.15. In 2025 the company made an earnings per share (EPS) of NZ$17.62 a decrease over its 2024 EPS that were of NZ$19.20.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$18.806.71%
2025NZ$17.62-8.25%
2024NZ$19.2044.94%
2023NZ$13.2527.26%
2022NZ$10.41-35.56%
2021NZ$16.1544.1%
2020NZ$11.2119.7%
2019NZ$9.36540.48%
2018NZ$1.46-76.07%
2017NZ$6.11-19.31%
2016NZ$7.57242.52%
2015NZ$2.21-62.87%
2014NZ$5.9513.43%
2013NZ$5.258.45%
2012NZ$4.84

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
NZ$42.32 121.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$19.77 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
NZ$33.75 76.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
NZ$3.60-81.20%๐Ÿ‡บ๐Ÿ‡ธ USA